nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—GRIK2—Parkinson's disease	0.404	0.539	CbGaD
Secobarbital—CHRNA4—Parkinson's disease	0.345	0.461	CbGaD
Secobarbital—CHRNA4—superior cervical ganglion—Parkinson's disease	0.00911	0.0866	CbGeAlD
Secobarbital—CHRNA4—adrenal medulla—Parkinson's disease	0.00747	0.071	CbGeAlD
Secobarbital—GRIK2—cerebellar cortex—Parkinson's disease	0.00638	0.0606	CbGeAlD
Secobarbital—GRIK2—telencephalic ventricle—Parkinson's disease	0.00371	0.0353	CbGeAlD
Secobarbital—CHRNA4—autonomic nervous system—Parkinson's disease	0.00334	0.0318	CbGeAlD
Secobarbital—CHRNA4—telencephalic ventricle—Parkinson's disease	0.00298	0.0283	CbGeAlD
Secobarbital—CHRNA4—peripheral nervous system—Parkinson's disease	0.00241	0.0229	CbGeAlD
Secobarbital—GRIK2—nerve—Parkinson's disease	0.00234	0.0222	CbGeAlD
Secobarbital—GRIA2—hindbrain—Parkinson's disease	0.00194	0.0184	CbGeAlD
Secobarbital—CHRNA4—nerve—Parkinson's disease	0.00188	0.0179	CbGeAlD
Secobarbital—GABRA6—hindbrain—Parkinson's disease	0.00187	0.0178	CbGeAlD
Secobarbital—GRIK2—hindbrain—Parkinson's disease	0.00175	0.0166	CbGeAlD
Secobarbital—CHRNA4—hindbrain—Parkinson's disease	0.00141	0.0134	CbGeAlD
Secobarbital—GABRB2—hindbrain—Parkinson's disease	0.00138	0.0131	CbGeAlD
Secobarbital—GABRA2—hindbrain—Parkinson's disease	0.00126	0.012	CbGeAlD
Secobarbital—GABRA1—hindbrain—Parkinson's disease	0.00122	0.0116	CbGeAlD
Secobarbital—GRIA2—embryo—Parkinson's disease	0.00121	0.0115	CbGeAlD
Secobarbital—GRIA2—brainstem—Parkinson's disease	0.00111	0.0106	CbGeAlD
Secobarbital—GABRA6—brainstem—Parkinson's disease	0.00107	0.0102	CbGeAlD
Secobarbital—GRIA2—forebrain—Parkinson's disease	0.00107	0.0102	CbGeAlD
Secobarbital—GABRA5—forebrain—Parkinson's disease	0.00101	0.00955	CbGeAlD
Secobarbital—GRIK2—brainstem—Parkinson's disease	0.001	0.00954	CbGeAlD
Secobarbital—CHRFAM7A—forebrain—Parkinson's disease	0.000977	0.00929	CbGeAlD
Secobarbital—GRIK2—forebrain—Parkinson's disease	0.000969	0.00921	CbGeAlD
Secobarbital—GABRA4—forebrain—Parkinson's disease	0.000912	0.00867	CbGeAlD
Secobarbital—CHRNA4—brainstem—Parkinson's disease	0.000807	0.00767	CbGeAlD
Secobarbital—GABRB2—brainstem—Parkinson's disease	0.00079	0.00751	CbGeAlD
Secobarbital—CHRNA7—forebrain—Parkinson's disease	0.000789	0.0075	CbGeAlD
Secobarbital—CHRNA4—forebrain—Parkinson's disease	0.000779	0.0074	CbGeAlD
Secobarbital—GABRG2—forebrain—Parkinson's disease	0.000763	0.00725	CbGeAlD
Secobarbital—GABRB2—forebrain—Parkinson's disease	0.000763	0.00725	CbGeAlD
Secobarbital—GABRA2—brainstem—Parkinson's disease	0.000722	0.00686	CbGeAlD
Secobarbital—GRIA2—midbrain—Parkinson's disease	0.000708	0.00673	CbGeAlD
Secobarbital—GRIK2—medulla oblongata—Parkinson's disease	0.0007	0.00665	CbGeAlD
Secobarbital—GABRA1—brainstem—Parkinson's disease	0.000698	0.00663	CbGeAlD
Secobarbital—GABRA2—forebrain—Parkinson's disease	0.000697	0.00662	CbGeAlD
Secobarbital—GRIA2—spinal cord—Parkinson's disease	0.000691	0.00657	CbGeAlD
Secobarbital—GABRA1—forebrain—Parkinson's disease	0.000674	0.0064	CbGeAlD
Secobarbital—CHRNA7—cardiovascular system—Parkinson's disease	0.000667	0.00634	CbGeAlD
Secobarbital—CHRNA4—cardiovascular system—Parkinson's disease	0.000658	0.00626	CbGeAlD
Secobarbital—GRIK2—midbrain—Parkinson's disease	0.00064	0.00608	CbGeAlD
Secobarbital—GRIK2—spinal cord—Parkinson's disease	0.000624	0.00593	CbGeAlD
Secobarbital—GRIA2—head—Parkinson's disease	0.000614	0.00584	CbGeAlD
Secobarbital—GABRA6—head—Parkinson's disease	0.000593	0.00564	CbGeAlD
Secobarbital—GRIA2—nervous system—Parkinson's disease	0.000582	0.00553	CbGeAlD
Secobarbital—GABRA5—head—Parkinson's disease	0.000576	0.00547	CbGeAlD
Secobarbital—GABRA6—nervous system—Parkinson's disease	0.000563	0.00535	CbGeAlD
Secobarbital—GRIA2—central nervous system—Parkinson's disease	0.000561	0.00533	CbGeAlD
Secobarbital—CHRFAM7A—head—Parkinson's disease	0.00056	0.00532	CbGeAlD
Secobarbital—GRIK2—head—Parkinson's disease	0.000555	0.00527	CbGeAlD
Secobarbital—GABRB2—medulla oblongata—Parkinson's disease	0.000551	0.00524	CbGeAlD
Secobarbital—GABRG2—medulla oblongata—Parkinson's disease	0.000551	0.00524	CbGeAlD
Secobarbital—GRIA2—cerebellum—Parkinson's disease	0.000548	0.00521	CbGeAlD
Secobarbital—GABRA5—nervous system—Parkinson's disease	0.000546	0.00519	CbGeAlD
Secobarbital—GABRA6—central nervous system—Parkinson's disease	0.000542	0.00515	CbGeAlD
Secobarbital—Butabarbital—GRIK2—Parkinson's disease	0.000541	0.0681	CrCbGaD
Secobarbital—GABRA3—head—Parkinson's disease	0.000536	0.00509	CbGeAlD
Secobarbital—CHRFAM7A—nervous system—Parkinson's disease	0.000531	0.00504	CbGeAlD
Secobarbital—GABRA6—cerebellum—Parkinson's disease	0.000529	0.00503	CbGeAlD
Secobarbital—GRIK2—nervous system—Parkinson's disease	0.000526	0.005	CbGeAlD
Secobarbital—GABRA5—central nervous system—Parkinson's disease	0.000525	0.00499	CbGeAlD
Secobarbital—GABRA4—head—Parkinson's disease	0.000522	0.00496	CbGeAlD
Secobarbital—CHRNA4—midbrain—Parkinson's disease	0.000514	0.00489	CbGeAlD
Secobarbital—Butethal—GRIK2—Parkinson's disease	0.000512	0.0645	CrCbGaD
Secobarbital—CHRFAM7A—central nervous system—Parkinson's disease	0.000511	0.00485	CbGeAlD
Secobarbital—GABRA3—nervous system—Parkinson's disease	0.000508	0.00483	CbGeAlD
Secobarbital—GRIK2—central nervous system—Parkinson's disease	0.000506	0.00481	CbGeAlD
Secobarbital—GABRB2—midbrain—Parkinson's disease	0.000504	0.00479	CbGeAlD
Secobarbital—GABRG2—midbrain—Parkinson's disease	0.000504	0.00479	CbGeAlD
Secobarbital—CHRNA4—spinal cord—Parkinson's disease	0.000502	0.00477	CbGeAlD
Secobarbital—Butalbital—GRIK2—Parkinson's disease	0.0005	0.0629	CrCbGaD
Secobarbital—GABRA4—nervous system—Parkinson's disease	0.000495	0.00471	CbGeAlD
Secobarbital—GRIK2—cerebellum—Parkinson's disease	0.000495	0.0047	CbGeAlD
Secobarbital—Aprobarbital—GRIK2—Parkinson's disease	0.000493	0.0621	CrCbGaD
Secobarbital—GABRG2—spinal cord—Parkinson's disease	0.000491	0.00467	CbGeAlD
Secobarbital—GABRB2—spinal cord—Parkinson's disease	0.000491	0.00467	CbGeAlD
Secobarbital—GABRA3—central nervous system—Parkinson's disease	0.000489	0.00465	CbGeAlD
Secobarbital—GABRA1—medulla oblongata—Parkinson's disease	0.000487	0.00463	CbGeAlD
Secobarbital—Thiopental—GRIK2—Parkinson's disease	0.000482	0.0607	CrCbGaD
Secobarbital—GABRA4—central nervous system—Parkinson's disease	0.000477	0.00453	CbGeAlD
Secobarbital—Amobarbital—GRIK2—Parkinson's disease	0.000476	0.0599	CrCbGaD
Secobarbital—GABRA4—cerebellum—Parkinson's disease	0.000466	0.00443	CbGeAlD
Secobarbital—Butabarbital—CHRNA4—Parkinson's disease	0.000463	0.0582	CrCbGaD
Secobarbital—CHRNA7—head—Parkinson's disease	0.000452	0.0043	CbGeAlD
Secobarbital—CHRNA4—head—Parkinson's disease	0.000446	0.00424	CbGeAlD
Secobarbital—GRIA2—brain—Parkinson's disease	0.000445	0.00423	CbGeAlD
Secobarbital—GABRA1—midbrain—Parkinson's disease	0.000445	0.00423	CbGeAlD
Secobarbital—Butethal—CHRNA4—Parkinson's disease	0.000438	0.0552	CrCbGaD
Secobarbital—GABRB2—head—Parkinson's disease	0.000437	0.00415	CbGeAlD
Secobarbital—GABRG2—head—Parkinson's disease	0.000437	0.00415	CbGeAlD
Secobarbital—GABRA1—spinal cord—Parkinson's disease	0.000434	0.00412	CbGeAlD
Secobarbital—GABRA6—brain—Parkinson's disease	0.00043	0.00409	CbGeAlD
Secobarbital—CHRNA7—nervous system—Parkinson's disease	0.000428	0.00407	CbGeAlD
Secobarbital—Butalbital—CHRNA4—Parkinson's disease	0.000427	0.0538	CrCbGaD
Secobarbital—CHRNA4—nervous system—Parkinson's disease	0.000423	0.00402	CbGeAlD
Secobarbital—Aprobarbital—CHRNA4—Parkinson's disease	0.000422	0.0531	CrCbGaD
Secobarbital—GABRA5—brain—Parkinson's disease	0.000417	0.00396	CbGeAlD
Secobarbital—GABRG2—nervous system—Parkinson's disease	0.000414	0.00394	CbGeAlD
Secobarbital—GABRB2—nervous system—Parkinson's disease	0.000414	0.00394	CbGeAlD
Secobarbital—CHRNA7—central nervous system—Parkinson's disease	0.000413	0.00392	CbGeAlD
Secobarbital—Thiopental—CHRNA4—Parkinson's disease	0.000412	0.0519	CrCbGaD
Secobarbital—Amobarbital—CHRNA4—Parkinson's disease	0.000407	0.0513	CrCbGaD
Secobarbital—CHRNA4—central nervous system—Parkinson's disease	0.000407	0.00387	CbGeAlD
Secobarbital—CHRFAM7A—brain—Parkinson's disease	0.000406	0.00385	CbGeAlD
Secobarbital—GRIK2—brain—Parkinson's disease	0.000402	0.00382	CbGeAlD
Secobarbital—Pentobarbital—GRIK2—Parkinson's disease	0.0004	0.0504	CrCbGaD
Secobarbital—GABRA2—head—Parkinson's disease	0.000399	0.00379	CbGeAlD
Secobarbital—GABRG2—central nervous system—Parkinson's disease	0.000399	0.00379	CbGeAlD
Secobarbital—GABRB2—central nervous system—Parkinson's disease	0.000399	0.00379	CbGeAlD
Secobarbital—CHRNA4—cerebellum—Parkinson's disease	0.000398	0.00378	CbGeAlD
Secobarbital—GABRG2—cerebellum—Parkinson's disease	0.00039	0.0037	CbGeAlD
Secobarbital—GABRB2—cerebellum—Parkinson's disease	0.00039	0.0037	CbGeAlD
Secobarbital—GABRA3—brain—Parkinson's disease	0.000388	0.00369	CbGeAlD
Secobarbital—GABRA1—head—Parkinson's disease	0.000386	0.00367	CbGeAlD
Secobarbital—GABRA4—brain—Parkinson's disease	0.000378	0.0036	CbGeAlD
Secobarbital—GABRA2—nervous system—Parkinson's disease	0.000378	0.0036	CbGeAlD
Secobarbital—Talbutal—GRIK2—Parkinson's disease	0.000368	0.0463	CrCbGaD
Secobarbital—GABRA1—nervous system—Parkinson's disease	0.000366	0.00348	CbGeAlD
Secobarbital—GABRA2—central nervous system—Parkinson's disease	0.000364	0.00346	CbGeAlD
Secobarbital—GABRA2—cerebellum—Parkinson's disease	0.000356	0.00338	CbGeAlD
Secobarbital—GABRA1—central nervous system—Parkinson's disease	0.000352	0.00335	CbGeAlD
Secobarbital—GABRA1—cerebellum—Parkinson's disease	0.000344	0.00327	CbGeAlD
Secobarbital—Pentobarbital—CHRNA4—Parkinson's disease	0.000342	0.0431	CrCbGaD
Secobarbital—CYP2C9—cardiovascular system—Parkinson's disease	0.000333	0.00316	CbGeAlD
Secobarbital—CHRNA7—brain—Parkinson's disease	0.000328	0.00311	CbGeAlD
Secobarbital—CHRNA4—brain—Parkinson's disease	0.000323	0.00307	CbGeAlD
Secobarbital—GABRG2—brain—Parkinson's disease	0.000317	0.00301	CbGeAlD
Secobarbital—GABRB2—brain—Parkinson's disease	0.000317	0.00301	CbGeAlD
Secobarbital—Talbutal—CHRNA4—Parkinson's disease	0.000314	0.0396	CrCbGaD
Secobarbital—Phenobarbital—GRIK2—Parkinson's disease	0.0003	0.0377	CrCbGaD
Secobarbital—GABRA2—brain—Parkinson's disease	0.000289	0.00275	CbGeAlD
Secobarbital—GABRA1—brain—Parkinson's disease	0.000279	0.00266	CbGeAlD
Secobarbital—Phenobarbital—CHRNA4—Parkinson's disease	0.000256	0.0323	CrCbGaD
Secobarbital—Thiopental—CYP2E1—Parkinson's disease	0.0002	0.0252	CrCbGaD
Secobarbital—CYP2C8—brain—Parkinson's disease	0.000184	0.00175	CbGeAlD
Secobarbital—Phenobarbital—CYP2E1—Parkinson's disease	0.000124	0.0157	CrCbGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	6.96e-05	0.000505	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—SLC6A3—Parkinson's disease	6.91e-05	0.000501	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	6.88e-05	0.000499	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—DLG4—Parkinson's disease	6.84e-05	0.000496	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—GRIN2B—Parkinson's disease	6.81e-05	0.000494	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—DLG4—Parkinson's disease	6.72e-05	0.000488	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—SLC6A3—Parkinson's disease	6.71e-05	0.000487	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	6.69e-05	0.000485	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	6.67e-05	0.000483	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	6.59e-05	0.000478	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	6.57e-05	0.000477	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—DLG4—Parkinson's disease	6.56e-05	0.000476	CbGpPWpGaD
Secobarbital—Phenobarbital—ABCB1—Parkinson's disease	6.52e-05	0.00821	CrCbGaD
Secobarbital—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	6.52e-05	0.000472	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—COMT—Parkinson's disease	6.5e-05	0.000472	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	6.48e-05	0.00047	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—MAOA—Parkinson's disease	6.46e-05	0.000468	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	6.45e-05	0.000468	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—COMT—Parkinson's disease	6.42e-05	0.000466	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	6.41e-05	0.000465	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—MAOA—Parkinson's disease	6.38e-05	0.000462	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	6.37e-05	0.000462	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	6.36e-05	0.000461	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—CASP3—Parkinson's disease	6.35e-05	0.000461	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	6.32e-05	0.000458	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	6.29e-05	0.000456	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.27e-05	0.000455	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.19e-05	0.000449	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	6.13e-05	0.000444	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—HSPA8—Parkinson's disease	6.11e-05	0.000443	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	6.09e-05	0.000441	CbGpPWpGaD
Secobarbital—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	6.06e-05	0.000439	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	6.05e-05	0.000439	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—COMT—Parkinson's disease	5.87e-05	0.000426	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—MAPK8—Parkinson's disease	5.84e-05	0.000423	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—MAOA—Parkinson's disease	5.83e-05	0.000423	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	5.79e-05	0.00042	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	5.78e-05	0.000419	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—CP—Parkinson's disease	5.77e-05	0.000419	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	5.75e-05	0.000417	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—DLG4—Parkinson's disease	5.73e-05	0.000416	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—COMT—Parkinson's disease	5.71e-05	0.000414	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—CP—Parkinson's disease	5.7e-05	0.000413	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—MAOA—Parkinson's disease	5.67e-05	0.000411	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.66e-05	0.000411	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	5.6e-05	0.000406	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—COMT—Parkinson's disease	5.6e-05	0.000406	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—MAOA—Parkinson's disease	5.56e-05	0.000403	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	5.52e-05	0.0004	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	5.52e-05	0.0004	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—COMT—Parkinson's disease	5.51e-05	0.000399	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.5e-05	0.000399	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—MAOA—Parkinson's disease	5.47e-05	0.000396	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	5.44e-05	0.000394	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.4e-05	0.000392	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—COMT—Parkinson's disease	5.37e-05	0.00039	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—MAOA—Parkinson's disease	5.33e-05	0.000387	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.31e-05	0.000385	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—CYP2D6—Parkinson's disease	5.25e-05	0.000381	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	5.21e-05	0.000378	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—CYP2D6—Parkinson's disease	5.18e-05	0.000376	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.18e-05	0.000376	CbGpPWpGaD
Secobarbital—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	5.18e-05	0.000375	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—Parkinson's disease	5.16e-05	0.000374	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	5.06e-05	0.000367	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	4.97e-05	0.000361	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	4.92e-05	0.000356	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	4.89e-05	0.000354	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—CYP2E1—Parkinson's disease	4.8e-05	0.000348	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	4.77e-05	0.000346	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.74e-05	0.000344	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	4.73e-05	0.000343	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	4.71e-05	0.000342	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—COMT—Parkinson's disease	4.7e-05	0.00034	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—MAOA—Parkinson's disease	4.66e-05	0.000338	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.53e-05	0.000328	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	4.39e-05	0.000319	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	4.33e-05	0.000314	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	4.28e-05	0.00031	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.22e-05	0.000306	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.2e-05	0.000305	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	4.17e-05	0.000302	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.16e-05	0.000302	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.11e-05	0.000298	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.06e-05	0.000294	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—COMT—Parkinson's disease	3.98e-05	0.000289	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTP1—Parkinson's disease	3.96e-05	0.000287	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—MAOA—Parkinson's disease	3.95e-05	0.000287	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.95e-05	0.000286	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—COMT—Parkinson's disease	3.93e-05	0.000285	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	3.91e-05	0.000284	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—GSTP1—Parkinson's disease	3.91e-05	0.000283	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.9e-05	0.000283	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.86e-05	0.00028	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	3.82e-05	0.000277	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.71e-05	0.000269	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	3.65e-05	0.000265	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTM1—Parkinson's disease	3.64e-05	0.000264	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.61e-05	0.000262	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	3.6e-05	0.000261	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—GSTM1—Parkinson's disease	3.59e-05	0.00026	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	3.59e-05	0.00026	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	3.58e-05	0.000259	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.58e-05	0.000259	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.57e-05	0.000259	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.54e-05	0.000257	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.48e-05	0.000252	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.46e-05	0.000251	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.43e-05	0.000249	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.4e-05	0.000247	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.4e-05	0.000246	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.39e-05	0.000246	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.39e-05	0.000246	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.34e-05	0.000242	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	3.34e-05	0.000242	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.3e-05	0.000239	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.29e-05	0.000239	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.26e-05	0.000236	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.25e-05	0.000236	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—COMT—Parkinson's disease	3.24e-05	0.000235	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	3.22e-05	0.000234	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	3.22e-05	0.000233	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	3.2e-05	0.000232	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	3.18e-05	0.000231	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.1e-05	0.000225	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.06e-05	0.000222	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.01e-05	0.000218	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.98e-05	0.000216	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.97e-05	0.000215	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	2.96e-05	0.000215	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.96e-05	0.000214	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	2.92e-05	0.000212	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.91e-05	0.000211	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.89e-05	0.00021	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.85e-05	0.000207	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.84e-05	0.000206	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.84e-05	0.000206	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.79e-05	0.000202	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—COMT—Parkinson's disease	2.77e-05	0.000201	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	2.77e-05	0.000201	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	2.77e-05	0.000201	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	2.76e-05	0.0002	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	2.75e-05	0.000199	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.74e-05	0.000199	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	2.73e-05	0.000198	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.72e-05	0.000197	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	2.72e-05	0.000197	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	2.6e-05	0.000189	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ND3—Parkinson's disease	2.58e-05	0.000187	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MCCC1—Parkinson's disease	2.58e-05	0.000187	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	2.53e-05	0.000184	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	2.5e-05	0.000181	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.48e-05	0.00018	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TALDO1—Parkinson's disease	2.43e-05	0.000176	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—OMD—Parkinson's disease	2.43e-05	0.000176	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.38e-05	0.000172	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	2.3e-05	0.000167	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.23e-05	0.000162	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GCH1—Parkinson's disease	2.2e-05	0.000159	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ND3—Parkinson's disease	2.1e-05	0.000152	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MCCC1—Parkinson's disease	2.1e-05	0.000152	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.1e-05	0.000152	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.98e-05	0.000144	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TALDO1—Parkinson's disease	1.98e-05	0.000143	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—OMD—Parkinson's disease	1.98e-05	0.000143	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—FBP1—Parkinson's disease	1.96e-05	0.000142	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—DBH—Parkinson's disease	1.96e-05	0.000142	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GBA—Parkinson's disease	1.96e-05	0.000142	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	1.91e-05	0.000138	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	1.87e-05	0.000136	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MCCC1—Parkinson's disease	1.8e-05	0.00013	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ND3—Parkinson's disease	1.8e-05	0.00013	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GCH1—Parkinson's disease	1.79e-05	0.00013	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—OMD—Parkinson's disease	1.69e-05	0.000122	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TALDO1—Parkinson's disease	1.69e-05	0.000122	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.61e-05	0.000117	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	1.6e-05	0.000116	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—FBP1—Parkinson's disease	1.59e-05	0.000115	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—DBH—Parkinson's disease	1.59e-05	0.000115	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GBA—Parkinson's disease	1.59e-05	0.000115	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GCH1—Parkinson's disease	1.53e-05	0.000111	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—DDC—Parkinson's disease	1.44e-05	0.000104	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.38e-05	9.98e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.36e-05	9.87e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GBA—Parkinson's disease	1.36e-05	9.87e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—DBH—Parkinson's disease	1.36e-05	9.87e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTA4—Parkinson's disease	1.36e-05	9.83e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.34e-05	9.71e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	1.22e-05	8.85e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MAOB—Parkinson's disease	1.21e-05	8.76e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—DDC—Parkinson's disease	1.17e-05	8.47e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.15e-05	8.34e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.1e-05	8e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.09e-05	7.9e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—DDC—Parkinson's disease	9.99e-06	7.24e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	9.94e-06	7.21e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MAOB—Parkinson's disease	9.84e-06	7.13e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTA4—Parkinson's disease	9.43e-06	6.84e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.36e-06	6.79e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.31e-06	6.75e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	8.98e-06	6.51e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CTGF—Parkinson's disease	8.82e-06	6.39e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	8.49e-06	6.16e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MAOB—Parkinson's disease	8.41e-06	6.1e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	8.22e-06	5.96e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—NQO1—Parkinson's disease	8.12e-06	5.89e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TH—Parkinson's disease	8.01e-06	5.81e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8e-06	5.8e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CYCS—Parkinson's disease	7.69e-06	5.57e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	7.31e-06	5.3e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CTGF—Parkinson's disease	7.18e-06	5.2e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—COMT—Parkinson's disease	6.81e-06	4.94e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTP1—Parkinson's disease	6.78e-06	4.91e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MAOA—Parkinson's disease	6.76e-06	4.9e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	6.69e-06	4.85e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—HMOX1—Parkinson's disease	6.68e-06	4.85e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—NQO1—Parkinson's disease	6.61e-06	4.79e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TH—Parkinson's disease	6.52e-06	4.73e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—ABCB1—Parkinson's disease	6.41e-06	4.65e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CYCS—Parkinson's disease	6.26e-06	4.54e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	6.25e-06	4.53e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTM1—Parkinson's disease	6.23e-06	4.52e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CTGF—Parkinson's disease	6.13e-06	4.45e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GPX1—Parkinson's disease	5.96e-06	4.32e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	5.71e-06	4.14e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—NQO1—Parkinson's disease	5.65e-06	4.1e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TH—Parkinson's disease	5.57e-06	4.04e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—COMT—Parkinson's disease	5.54e-06	4.02e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTP1—Parkinson's disease	5.52e-06	4e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—MTHFR—Parkinson's disease	5.5e-06	3.99e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MAOA—Parkinson's disease	5.5e-06	3.99e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—HMOX1—Parkinson's disease	5.44e-06	3.94e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CYCS—Parkinson's disease	5.35e-06	3.88e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—ABCB1—Parkinson's disease	5.22e-06	3.79e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—APOE—Parkinson's disease	5.12e-06	3.71e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTM1—Parkinson's disease	5.07e-06	3.67e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GPX1—Parkinson's disease	4.85e-06	3.52e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—COMT—Parkinson's disease	4.74e-06	3.43e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTP1—Parkinson's disease	4.71e-06	3.42e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MAOA—Parkinson's disease	4.7e-06	3.41e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—HMOX1—Parkinson's disease	4.65e-06	3.37e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—MTHFR—Parkinson's disease	4.48e-06	3.25e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—ABCB1—Parkinson's disease	4.46e-06	3.23e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—INS—Parkinson's disease	4.38e-06	3.17e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTM1—Parkinson's disease	4.33e-06	3.14e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—APOE—Parkinson's disease	4.17e-06	3.02e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GPX1—Parkinson's disease	4.15e-06	3.01e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—MTHFR—Parkinson's disease	3.83e-06	2.78e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—APOE—Parkinson's disease	3.56e-06	2.58e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—INS—Parkinson's disease	3.56e-06	2.58e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—INS—Parkinson's disease	3.04e-06	2.21e-05	CbGpPWpGaD
